Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo‐controlled trial (LIBERATE)
PaperCitations, authors & open-access status
The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo‐controlled trial (LIBERATE) is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 200 citations, 2016 year and hybrid oa status.
200
Citations
2016
Year
hybrid
OA Status